134 related articles for article (PubMed ID: 15303999)
1. Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003.
Leong HN; Ang B; Earnest A; Teoh C; Xu W; Leo YS
Trop Med Int Health; 2004 Aug; 9(8):923-7. PubMed ID: 15303999
[TBL] [Abstract][Full Text] [Related]
2. Adverse effects of ribavirin and outcome in severe acute respiratory syndrome: experience in two medical centers.
Chiou HE; Liu CL; Buttrey MJ; Kuo HP; Liu HW; Kuo HT; Lu YT
Chest; 2005 Jul; 128(1):263-72. PubMed ID: 16002945
[TBL] [Abstract][Full Text] [Related]
3. Severe acute respiratory syndrome: clinical outcome and prognostic correlates.
Tsui PT; Kwok ML; Yuen H; Lai ST
Emerg Infect Dis; 2003 Sep; 9(9):1064-9. PubMed ID: 14519241
[TBL] [Abstract][Full Text] [Related]
4. Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome.
Muller MP; Dresser L; Raboud J; McGeer A; Rea E; Richardson SE; Mazzulli T; Loeb M; Louie M;
Pharmacotherapy; 2007 Apr; 27(4):494-503. PubMed ID: 17381375
[TBL] [Abstract][Full Text] [Related]
5. Outcome of coronavirus-associated severe acute respiratory syndrome using a standard treatment protocol.
Lau AC; So LK; Miu FP; Yung RW; Poon E; Cheung TM; Yam LY
Respirology; 2004 Jun; 9(2):173-83. PubMed ID: 15182266
[TBL] [Abstract][Full Text] [Related]
6. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings.
Chu CM; Cheng VC; Hung IF; Wong MM; Chan KH; Chan KS; Kao RY; Poon LL; Wong CL; Guan Y; Peiris JS; Yuen KY;
Thorax; 2004 Mar; 59(3):252-6. PubMed ID: 14985565
[TBL] [Abstract][Full Text] [Related]
7. Ribavirin in the treatment of severe acute respiratory syndrome (SARS).
van Vonderen MG; Bos JC; Prins JM; Wertheim-van Dillen P; Speelman P
Neth J Med; 2003 Jul; 61(7):238-41. PubMed ID: 14567520
[No Abstract] [Full Text] [Related]
8. Ribavirin for SARS in children.
Cheng WT; Li CK; Leung TF; Li AM; Hon KL; Ng PC; Fok TF
Clin Pediatr (Phila); 2004 Mar; 43(2):193-6. PubMed ID: 15024445
[No Abstract] [Full Text] [Related]
9. High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome.
Ho JC; Ooi GC; Mok TY; Chan JW; Hung I; Lam B; Wong PC; Li PC; Ho PL; Lam WK; Ng CK; Ip MS; Lai KN; Chan-Yeung M; Tsang KW
Am J Respir Crit Care Med; 2003 Dec; 168(12):1449-56. PubMed ID: 12947028
[TBL] [Abstract][Full Text] [Related]
10. Clinical trials and novel pathogens: lessons learned from SARS.
Muller MP; McGeer A; Straus SE; Hawryluck L; Gold WL
Emerg Infect Dis; 2004 Mar; 10(3):389-94. PubMed ID: 15109402
[TBL] [Abstract][Full Text] [Related]
11. Severe acute respiratory syndrome in children: experience in a regional hospital in Hong Kong.
Chiu WK; Cheung PC; Ng KL; Ip PL; Sugunan VK; Luk DC; Ma LC; Chan BH; Lo KL; Lai WM
Pediatr Crit Care Med; 2003 Jul; 4(3):279-83. PubMed ID: 12831407
[TBL] [Abstract][Full Text] [Related]
12. [Clinical diagnosis, treatment and prognosis of elderly SARS patients].
Cao B; Liu ZY; Wang MZ; Cai BQ; Xu ZJ; Bai Y; Zhu YJ; Xu WB; Lu WX; Li LY; Li TS; Wang Z
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):547-9. PubMed ID: 14650155
[TBL] [Abstract][Full Text] [Related]
13. Temporal relationship of viral load, ribavirin, interleukin (IL)-6, IL-8, and clinical progression in patients with severe acute respiratory syndrome.
Wang WK; Chen SY; Liu IJ; Kao CL; Chen HL; Chiang BL; Wang JT; Sheng WH; Hsueh PR; Yang CF; Yang PC; Chang SC;
Clin Infect Dis; 2004 Oct; 39(7):1071-5. PubMed ID: 15472864
[TBL] [Abstract][Full Text] [Related]
14. Severe acute respiratory syndrome vs. the Middle East respiratory syndrome.
Hui DS; Memish ZA; Zumla A
Curr Opin Pulm Med; 2014 May; 20(3):233-41. PubMed ID: 24626235
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy outcome after exposure to injectable ribavirin during embryogenesis.
Rezvani M; Koren G
Reprod Toxicol; 2006 Jan; 21(1):113-5. PubMed ID: 16122903
[TBL] [Abstract][Full Text] [Related]
16. Medical treatment of viral pneumonia including SARS in immunocompetent adult.
Cheng VC; Tang BS; Wu AK; Chu CM; Yuen KY
J Infect; 2004 Nov; 49(4):262-73. PubMed ID: 15474623
[TBL] [Abstract][Full Text] [Related]
17. Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada.
Knowles SR; Phillips EJ; Dresser L; Matukas L
Clin Infect Dis; 2003 Oct; 37(8):1139-42. PubMed ID: 14523782
[TBL] [Abstract][Full Text] [Related]
18. A young infant with severe acute respiratory syndrome.
Sit SC; Yau EK; Lam YY; Ng DK; Fong NC; Hui YW; Cheng WF; Leung CW; Chiu MC
Pediatrics; 2003 Oct; 112(4):e257. PubMed ID: 14523208
[TBL] [Abstract][Full Text] [Related]
19. The use of corticosteroids in SARS.
Oba Y
N Engl J Med; 2003 May; 348(20):2034-5; author reply 2034-5. PubMed ID: 12748321
[No Abstract] [Full Text] [Related]
20. Lupus pneumonitis or severe acute respiratory syndrome?
Mok CC; Ying KY
Lupus; 2004; 13(7):549-53. PubMed ID: 15352429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
